Search results: Sage Journals

Open accessResearch articleFirst published 2026

Bridging Global Attention and Local Hierarchies: A Robust Hybrid Ensemble Framework With Multi-Perspective Explainability for Automated HER2-IHC Scoring

Hossam Magdy Balaha, Norah Saleh Alghamdi, Nithya Rekha Sivakumar [...]

Technology in Cancer Research & Treatment

Free accessResearch articleFirst published January, 2018

Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer

Young San Ko, Nae Yu Kim, Jung-Soo Pyo

The International Journal of Biological Markers

Free accessResearch articleFirst published October, 2016

Clinicopathological Significance and Diagnostic Accuracy of HER2 Immunohistochemistry in Colorectal Cancer: A Meta-Analysis

Jung-Soo Pyo, Guhyun Kang, Kyeongmee Park

The International Journal of Biological Markers

Free accessReview articleFirst published 2016

Concordance Rate between HER2 Immunohistochemistry and in Situ Hybridization in Gastric Carcinoma: Systematic Review and Meta-Analysis

Jung-Soo Pyo, Jin Hee Sohn, Woo Ho Kim

The International Journal of Biological Markers

Open accessResearch articleFirst published 2025

Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and Scoring Concordance Among Pathologists

Maher Sughayer, Ghada Al-Jussani, Ahmed Salem [...]

Breast Cancer: Basic and Clinical Research

Open accessResearch articleFirst published 2025

Comparative Analysis of Equivocal (2+) and Positive (3+) HER2 Immunohistochemistry (IHC) and Bright-Field Dual-Color In Situ Hybridization (DISH) in Primary Breast Cancer From 1,307 Node-Positive Patients

Kroonpong Iampenkhae, Adiluck Pisutpunya, Chawinthorn Vuthithammee [...]

Breast Cancer: Basic and Clinical Research

Free accessResearch articleFirst published 2016

Evaluation of HER2 by Automated FISH and IHC in Gastric Carcinoma Biopsies

Maria R. Silva, Ana Alarcão, Teresa Ferreira [...]

The International Journal of Biological Markers

Open accessReview articleFirst published 2023

The HER2-low revolution in breast oncology: steps forward and emerging challenges

Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano [...]

Therapeutic Advances in Medical Oncology

Open accessCase reportFirst published 2022

Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature

Cheukfai Li, Chongyang Ren, Lingzhu Wen [...]

Clinical Medicine Insights: Oncology

Open accessResearch articleFirst published 2023

Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis

Lanyi Dai, Qiyuan Huang, Rong Guo [...]

Clinical Medicine Insights: Oncology

Open accessResearch articleFirst published 2026

Bridging Global Attention and Local Hierarchies: A Robust Hybrid Ensemble Framework With Multi-Perspective Explainability for Automated HER2-IHC Scoring

Hossam Magdy Balaha, Norah Saleh Alghamdi, Nithya Rekha Sivakumar [...]

Technology in Cancer Research & Treatment

Free accessResearch articleFirst published January, 2018

Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer

Young San Ko, Nae Yu Kim, Jung-Soo Pyo

The International Journal of Biological Markers

Free accessResearch articleFirst published October, 2016

Clinicopathological Significance and Diagnostic Accuracy of HER2 Immunohistochemistry in Colorectal Cancer: A Meta-Analysis

Jung-Soo Pyo, Guhyun Kang, Kyeongmee Park

The International Journal of Biological Markers

Free accessReview articleFirst published 2016

Concordance Rate between HER2 Immunohistochemistry and in Situ Hybridization in Gastric Carcinoma: Systematic Review and Meta-Analysis

Jung-Soo Pyo, Jin Hee Sohn, Woo Ho Kim

The International Journal of Biological Markers

Open accessResearch articleFirst published 2025

Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and Scoring Concordance Among Pathologists

Maher Sughayer, Ghada Al-Jussani, Ahmed Salem [...]

Breast Cancer: Basic and Clinical Research

Open accessResearch articleFirst published 2025

Comparative Analysis of Equivocal (2+) and Positive (3+) HER2 Immunohistochemistry (IHC) and Bright-Field Dual-Color In Situ Hybridization (DISH) in Primary Breast Cancer From 1,307 Node-Positive Patients

Kroonpong Iampenkhae, Adiluck Pisutpunya, Chawinthorn Vuthithammee [...]

Breast Cancer: Basic and Clinical Research

Free accessResearch articleFirst published 2016

Evaluation of HER2 by Automated FISH and IHC in Gastric Carcinoma Biopsies

Maria R. Silva, Ana Alarcão, Teresa Ferreira [...]

The International Journal of Biological Markers

Open accessReview articleFirst published 2023

The HER2-low revolution in breast oncology: steps forward and emerging challenges

Eleonora Nicolò, Luca Boscolo Bielo, Giuseppe Curigliano [...]

Therapeutic Advances in Medical Oncology

Open accessCase reportFirst published 2022

Heterogenous and Low Expression of HER2 in Breast Cancer Overcome by DS-8201a in a Heavily Treated Patient: Case Report and Review of the Literature

Cheukfai Li, Chongyang Ren, Lingzhu Wen [...]

Clinical Medicine Insights: Oncology

Open accessResearch articleFirst published 2023

Clinicopathologic Features and Prognosis of Female Early Breast Cancer With HER2 Low Expression: A Propensity Score Matched Analysis

Lanyi Dai, Qiyuan Huang, Rong Guo [...]

Clinical Medicine Insights: Oncology